[1] Abbasi R,Shineh G,Mobaraki M .2023 .Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review. J Nanopart Res, 25(3) : 43.
[2] Abdolmohammadi Khiav L and Zahmatkesh A .2021 .Vaccination against pathogenic clostridia in animals: A review. Trop Anim Health Prod 53, (2) : 284.
[3] Ahmed HA,El Bayomi RM,Hamed RI .2022 .Genetic relatedness, antibiotic resistance, and effect of silver nanoparticle on biofilm formation by Clostridium perfringens isolated from chickens, pigeons, camels, and human consumers. Vet Sci: 9, (3) : 109.
[4] Akerele G,Ramadan N,Renu S .2020 .In vitro characterization and immunogenicity of chitosan nanoparticles loaded with native and inactivated extracellular proteins from a field strain of Clostridium perfringens associated with necrotic enteritis. Vet Immunol Immunopathol, 224 : 110059.
[5] Alizadeh M,Shojadoost B,Boodhoo N .2021 .Necrotic enteritis in chickens: A review of pathogenesis, immune responses and prevention, focusing on probiotics and vaccination. Anim Health Res Rev, 22(2) : 147-162.
[6] Anju K,Karthik K,Divya V .2021 .Toxinotyping and molecular characterization of antimicrobial resistance in Clostridium perfringens isolated from different sources of livestock and poultry. Anaerobe, 67 : 102298.
[7] Balali GI,Yar DD,Afua Dela DD .2020 .Microbial contamination, an increasing threat to the consumption of fresh fruits and vegetables in today's world. Int J Microbiol, : 3029295.
[8] Balog S,de Almeida MS,Taladriz-Blanco P .2024 .Does the surface charge of the nanoparticles drive nanoparticle-cell membrane interactions. Curren opin Biotehc, 87 : 103128.
[9] Banerji R,Karkee A,Kanojiya P .2021 .Pore‐forming toxins of foodborne pathogens. Compr Rev Food Sci Food Safe, 20(3) : 2265-2285.
[10] Begines B,Ortiz T,Pérez-Aranda M .2020 .Polymeric nanoparticles for drug delivery: Recent developments and future prospects. Nanomater, 10(7) : 1403.
[11] Bendary MM,Abd El-Hamid MI,El-Tarabili RM .2022 .Clostridium perfringens associated with foodborne infections of animal origins: Insights into prevalence, antimicrobial resistance, toxin genes profiles, and toxinotypes. Biology, 11(4) : 551.
[12] Benz R,Piselli C,Hoxha C .2022 .Clostridium perfringens Beta2 toxin forms highly cation-selective channels in lipid bilayers. Euro Biophys J, 51(1) : 15-27.
[13] Bhardwaj LK,Rath P,Choudhury M .2023 .A comprehensive review on the classification, uses, sources of nanoparticles (NPs) and their toxicity on health. Aerosol Sci Engg, 7(1) : 69-86.
[14] Bhat MA,Gedik K,Gaga EO,Bhattacharjee R,Negi A,Bhattacharya B .2023 .Nanotheranostics to target antibiotic-resistant bacteria: Strategies and applications. OpenNano, 11 : 100138.
[15] Bochani S,Zarepour A,Kalantari-Hesari A .2023 .oxygen-releasing chitosan-based hydrogel for multimodal healing of bacteria-infected wounds. J Mater Chemistry, 33 : 8056-8068.
[16] Boulianne M,Uzal FA,Opengart K .2020 .Clostridial diseases. Diseases of Poultry. Willey Online Library, : 966-994.
[17] Brar B,Marwaha S,Poonia AK .2023 .Nanotechnology: a contemporary therapeutic approach in combating infections from multidrug-resistant bacteria. Arch Microbiol, 205(2) : 62.
[18] Camargo A,Guerrero-Araya E,Castañeda S .2022 .Intra-species diversity of Clostridium perfringens: A diverse genetic repertoire reveals its pathogenic potential. Front Microbiol, 13 : 952081.
[19] Campos PM,Miska KB,Jenkins MC .2024 .Effects of Eimeria acervulina infection on the luminal and mucosal microbiota of the cecum and ileum in broiler chickens. Sci Rep, 14(1) : 10702.
[20] Cong VT,Houng JL,Kavallaris M .2022 .How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells?. Chem Socie Rev, 51(17) : 7531-7559.
[21] Csaba N,Garcia-Fuentes M,Alonso MJ M .2009 .Nanoparticles for nasal vaccination. Adv Drug Deliv Rev, 61(2) : 140-157.
[22] Dmour I,Islam N .2022 .Recent advances on chitosan as an adjuvant for vaccine delivery. Int J Biolog Macromol, 200 : 498-519.
[23] Dykman LA .2020 .Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases. Expert Rev Vacc, 19(5) : 465-477.
[24] Eleraky NE,Allam A,Hassan SB .2020 .Nanomedicine fight against antibacterial resistance: an overview of the recent pharmaceutical innovations. Pharmaceutics, 12(2) : 142.
[25] Epple M,Rotello VM,Dawson K .2023 .The why and how of ultrasmall nanoparticles. Accounts Chem Res, 56(23) : 3369-3378.
[26] Fancher CA,Zhang L,Kiess AS .2020 .Avian pathogenic Escherichia coli and Clostridium perfringens: Challenges in no antibiotics ever broiler production and potential solutions. Microorganis, 8(10) : 1533.
[27] Fathima S,Hakeem WGA,Shanmugasundaram R .1958 .Necrotic enteritis in broiler chickens: a review on the pathogen, pathogenesis, and prevention. Microorganis, 10(10) : .
[28] Fatima A,Zaheer T,Pal K .2024 .Zinc oxide nanoparticles significant role in poultry and novel toxicological mechanisms. Biolog Trace Elem Res, 202(1) : 268-290.
[29] Finnie JW,Uzal FA .2022 .Pathology and pathogenesis of brain lesions produced by Clostridium perfringens type D epsilon toxin. Int J Mol Sci, 23(16) : 9050.
[30] Fu Y,Alenezi T,Sun X .2022 .Clostridium perfringens-induced necrotic diseases: an overview. Immuno, 2(2) : 387-407.
[31] Godoy-Gallardo M,Eckhard U,Delgado LM .2021 .Antibacterial approaches in tissue engineering using metal ions and nanoparticles: From mechanisms to applications. Bioact Mater, 6(12) : 4470-4490.
[32] Gomaa NH,El-Aziz NKA,El-Naenaeey E .2023 .Antimicrobial potential of myricetin-coated zinc oxide nanocomposite against drug-resistant Clostridium perfringens. BMC Microbiol, 23(1) : 79.
[33] Grenda T,Jarosz A,Sapała M .2023 .Clostridium perfringensopportunistic Foodborne Pathogen, its diversity and epidemiological significance. Pathogens, 12(6) : 768.
[34] Guan G,Zhang L,Zhu J .2021 .Antibacterial properties and mechanism of biopolymer-based films functionalized by CuO/ZnO nanoparticles against Escherichia coli and Staphylococcus aureus. J Hazard Mater, 402 : 123542.
[35] Gudkov SV,Burmistrov DE,Serov DA .2021 .A mini review of antibacterial properties of ZnO nanoparticles. Front Phys, 9 : 641481.
[36] He W,Goes EC,Wakaruk J .2022 .A poultry subclinical necrotic enteritis disease model based on natural Clostridium perfringens uptake. Front Physiol, 13 : 788592.
[37] Heidarpanah S,Thibodeau A,Parreira VR .2023 .Immunization of broiler chickens with five newly identified surface-exposed proteins unique to Clostridium perfringens causing necrotic enteritis. Sci Rep, 13(1) : 5254.
[38] Hernández-Abril PA,López-Meneses AK,Lizardi-Mendoza J .2024 .Cellular internalization and toxicity of chitosan nanoparticles loaded with nobiletin in eukaryotic cell models (Saccharomyces cerevisiae and Candida albicans). Mater, 17(7) : 1525.
[39] Hoseini ZS,Hajizade A,Razmyar J .2021 .Mesoporous silica nanoparticles-based formulations of a chimeric proteinous vaccine candidate against necrotic enteritis disease. Mater Sci Engg C, 128 : 112316.
[40] Hu W,Wang C,Gao D .2023 .Toxicity of transition metal nanoparticles: A review of different experimental models in the gastrointestinal tract. J appl Toxicl, 43(1) : 32-46.
[41] Huang .2023 .Molecular characterization of Clostridium perfringens isolates from a tertiary children's hospital in Guangzhou, China, establishing an association between bacterial colonization and food allergies in infants. Gut Path, 15(1) : 47.
[42] Hussain H,Fadel A,Garcia E .2024 .Clostridial myonecrosis: A comprehensive review of toxin pathophysiology and management strategies. Microorganis, 12(7) : .
[43] Hussain R,Guangbin Z,Abbas RZ .2022 .Clostridium perfringens types A and D involved in peracute deaths in goats kept in cholistan ecosystem during winter season. Front Vet Sci, 9 : 849856.
[44] Hustá M,Ducatelle R,Haesebrouck F .2020 .A comparative study on the use of selective media for the enumeration of Clostridium perfringens in poultry faeces. Anaerobe, 63 : 102205.
[45] Ibrahim D,Ismail TA,Khalifa E .2027 .Supplementing garlic nanohydrogel optimized growth, gastrointestinal integrity and economics and ameliorated necrotic enteritis in broiler chickens using a Clostridium perfringens challenge model. Anim, 11(7) : .
[46] Ibrahim RE,Fouda MMS,Younis EM .2024 .The anti-bacterial efficacy of zinc oxide nanoparticles synthesized by Nelumbo nucifera leaves against Clostridium perfringens challenge in Oreochromis niloticus. Aquaculture, 578 : 740030.
[47] Ingole R,Ingle P,Gade A .2023 .Application of mycosynthesized nanoparticles in veterinary sciences, myconanotechnology. , : 276-298.
[48] Jiang Z,Chang J,Wang F .2020 .Etx-Y71A as a non-toxic mutant of Clostridium perfringens epsilon toxin induces protective immunity in mice and sheep. Vaccine, 38(42) : 6553-6561.
[49] Jiménez-Jiménez C,Manzano M,Vallet-Regí M .2020 .Nanoparticles coated with cell membranes for biomedical applications. Biology, 9(11) : 406.
[50] Kalender H,Öngör H,Timurkaan N .2023 .Detection and molecular characterization of Clostridium perfringens, Paeniclostridium sordellii and Clostridium septicum from lambs and goat kids with hemorrhagic abomasitis in Turkey. BMC Vet Res, 19(1) : 8.
[51] Kanaan MHG,Tarek AM .2020 .Clostridium botulinum, a foodborne pathogen and its impact on public health. Ann Trop Med Publ Health, 23(5) : 49-62.
[52] Kannan P,Ruban SW,Quintoil MN,Techniques Engineering,Khan B,Channo A,Rajput R .2023 .Animals to human transmission of intestinal diseases: a review of the mechanism and factors involved. , : 29-45.
[53] Khan MUZ,Humza M,Yang S .2021 .Evaluation and optimization of antibiotics resistance profile against Clostridium perfringens from buffalo and cattle in Pakistan. Antibiotics, 10(1) : 59.
[54] Koirala P,Chen SPR,Boer JC .2023 .Polymeric nanoparticles as a self‐adjuvanting peptide vaccine delivery system: The role of shape. Adv Funct Mater, 33(12) : 2209304.
[55] Kongkham B,Prabakaran D,Puttaswamy H .2020 .Opportunities and challenges in managing antibiotic resistance in bacteria using plant secondary metabolites. Fitoterapia, 147 : 104762.
[56] Kowalczyk P,Strzępa A,Szczepanik M .2021 .Perinatal treatment of parents with the broad-spectrum antibiotic enrofloxacin aggravates contact sensitivity in adult offspring mice. Pharmacol Rep, 73 : 664-671.
[57] Kuo J,Uzunovic J,Jacobson A .2024 .Toxigenic Clostridium perfringens isolated from at-risk paediatric inflammatory bowel disease patients. J Crohn Colitis, 18(7) : 985-1001.
[58] Lan-Xin OU,Bijin YE,Mingfei S .2024 .mechanisms of intestinal epithelial cell damage by Clostridium perfringens. Anaerobe, 87 : 102856.
[59] Lee K-W and Lillehoj HS .2021 .Role of Clostridium perfringens necrotic enteritis B-like toxin in disease pathogenesis. Vaccines, 10(1) : 61.
[60] Lhermie G,La Ragione RM,Weese JS .2020 .Indications for the use of highest priority critically important antimicrobials in the veterinary sector. J Antimicrob Chemotherap, 75(7) : 1671-1680.
[61] Li X,Chen D,Xie S .2021 .Current progress and prospects of organic nanoparticles against bacterial biofilm. Adv Colloid Interf Sci, 294 : 102475.
[62] Linklater DP,Baulin VA,Le Guével X .2020 .Antibacterial action of nanoparticles by lethal stretching of bacterial cell membranes. Adv Mater, 32(52) : 2005679.
[63] Liu WL,Zou MZ,Qin SY .2020 .Recent advances of cell membrane‐coated nanomaterials for biomedical applications. Advanced Functional Materials, 30(39) : 2003559.
[64] Lopes J,Ferreira-Gonçalves T,Ascensão L .2023 .Safety of gold nanoparticles: from in vitro to in vivo testing array checklist. Pharmaceutics, 15(4) : 1120.
[65] Mabrouk M,Das DB,Salem ZA .2021 .Nanomaterials for biomedical applications: production, characterisations, recent trends and difficulties. Molecules, 26(4) : 1077.
[66] Mada T,Goto Y,Kumagai M .2023 .A calf with hind limb paralysis and dysstasia and a genome sequence analysis of an isolated Clostridium perfringens toxinotype E strain. J Vet Med Sci, 85(3) : 279-289.
[67] Makvandi P,Chen M,Sartorius R .2021 .Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking. Nano Today, 40 : 101279.
[68] Maťátková O,Michailidu J,Miškovská A .2022 .Antimicrobial properties and applications of metal nanoparticles biosynthesized by green methods. Biotevhnol Adv, 58 : 107905.
[69] Mehdizadeh Gohari I,A. Navarro M,Li J .2021 .Pathogenicity and virulence of Clostridium perfringens. Virulence, 12(1) : 723-753.
[70] Mohd Yusof H,Abdul Rahman NA,Mohamad R .2093 .Antibacterial potential of biosynthesized zinc oxide nanoparticles against poultry-associated foodborne pathogens: an in vitro study. Animals, 11(7) : .
[71] Mora ZV,Macías-Rodríguez ME,Arratia-Quijada J .2020 .Clostridium perfringens as foodborne pathogen in broiler production: pathophysiology and potential strategies for controlling necrotic enteritis. Animals, 10(9) : 1718.
[72] Naveed M,Chaudhry Z,Bukhari SA .2020 .Antibiotics resistance mechanism, Antibiotics and Antimicrobial Resistance Genes in the Environment. , : 292-312.
[73] Niculescu A-G and Grumezescu AM .2022 .Applications of ChitosanAlginate-Based Nanoparticles-An Up-to-Date Review. Nanomater, 12(2) : 186.
[74] Packialakshmi JS,Kang J,Jayakumar A .2023 .Insights into the antibacterial and antiviral mechanisms of metal oxide nanoparticles used in food packaging. Food Packag Shelf Life, 40 : 101213.
[75] Poorhassan F,Nemati F,Saffarian P .2021 .Design of a chitosanbased nano vaccine against epsilon toxin of Clostridium perfringens type D and evaluation of its immunogenicity in BALB/c mice. Res Pharmaceut Sci, 16(6) : 575-585.
[76] Pudineh Moarref M,Alimolaei M,Emami T .2023 .Development and evaluation of cell membrane-based biomimetic nanoparticles loaded by Clostridium perfringens epsilon toxin: a novel vaccine delivery platform for Clostridial-associated diseases. Nanotoxicol, 17(5) : 420-431.
[77] Rajak BL,Kumar R,Gogoi M .2020 .Antimicrobial activity of nanomaterials. Nanosci Med, 1 : 147-185.
[78] Ren R,Lim C,Li S,carbon- S .2022 .and polymer-based nanomaterials for antibacterial applications. Nanomaterial, 12(21) : 3855.
[79] Rizk AM,Asal AM,El-Tawab A .2023 .Antibiogram pattern and molecular characterization of Clostridium perfringens isolated from different species. Benha Vet Med J, 43(2) : 69-74.
[80] Rizk AM,El-Tawab A,Awad A .2020 .Prevalence of Clostridium perfringens infection and virulence genes molecular study in broiler chickens. Benha Vet Med J, 38(1) : 70-74.
[81] Dos Santos Junior Rodrigues,Kelley Lopes da Silva S,Santos Dias F .2020 .Intranasal vaccine using P10 peptide complexed within chitosan polymeric nanoparticles as experimental therapy for paracoccidioidomycosis in murine model. J Fungi, 6(3) : 160.
[82] Rosli NA,Teow YH,Mahmoudi E .2021 .Current approaches for the exploration of antimicrobial activities of nanoparticles. Sci Tech Adv Mater, 22(1) : 885-907.
[83] Saadh MJ,Lafi FF,Dahadha AA .2022 .Immunogenicity of a newly developed vaccine against Clostridium perfringens alpha-toxin in rabbits and cattle. Vet World, 15(7) : 1617.
[84] Saberi Riseh R,Gholizadeh Vazvani M,Hassanisaadi M .2023 .Micro-/nano-carboxymethyl cellulose as a promising biopolymer with prospects in the agriculture sector: a review. Polymers, 15(2) : 440.
[85] Salleh A,Naomi R,Utami ND .2020 .The potential of silver nanoparticles for antiviral and antibacterial applications: A mechanism of action. Nanomater, 10(8) : 1566.
[86] Şenel S and Yüksel S .2020 .Chitosan-based particulate systems for drug and vaccine delivery in the treatment and prevention of neglected tropical diseases. Drug Deliv Translat Res, 10 : 1644-1674.
[87] Shakal M,Khalefa HS,Salem HM .2024 .Estimation of the antibacterial activity of zinc oxide nanoparticles against induced Clostridium perfringens infection in broiler chickens. J Adv Vet Res, 14(4) : 710-714.
[88] Shamshirgaran MA,Golchin M .2024 .A comprehensive review of experimental models and induction protocols for avian necrotic enteritis over the past 2 decades. Front Vet Sci, 11 : 1429637.
[89] Shanker R,Singh G,Jyoti A,Takehara M,Bandou H,Kobayashi K .2020 .Clostridium perfringens α-toxin specifically induces endothelial cell death by promoting ceramide-mediated apoptosis. Anaerobe, 65 : 102262.
[90] Talukdar PK,Sarker MR .2022 .Characterization of putative sporulation and germination genes in Clostridium perfringens Food-Poisoning Strain SM101. Microorganis, 10(8) : 1481.
[91] Thapa RK,Diep DB,Tønnesen HH .2021 .Nanomedicine-based antimicrobial peptide delivery for bacterial infections: Recent advances and future prospects. J Pharmaceut Invest, 51 : 377-398.
[92] Tungare K,Gupta J,Bhori M .2024 .Nanomaterial in controlling biofilms and virulence of microbial pathogens. Microbial Pathogenesis, 192 : 106722.
[93] Uruén C,Chopo-Escuin G,Tommassen J .2020 .Biofilms as promoters of bacterial antibiotic resistance and tolerance. Antibiotics, 10(1) : 3.
[94] Vamsi Krishna K,Bharathi N .2022 .An updated review on advancement in fermentative production strategies for biobutanol using Clostridium spp. Environ Sci Pollut Res, 29(32) : 47988-48019.
[95] Vassallo A,Silletti MF,Faraone I .2020 .Nanoparticulate antibiotic systems as antibacterial agents and antibiotic delivery platforms to fight infections. J Nanomater, 1 : 6905631.
[96] Wahdan A,Elhaig MM .2024 .Epidemiology and diagnostic accuracy of Clostridium perfringens toxins in the intestinal contents of camels, sheep, and cattle: a cross-sectional study in Dakahlia governorate. Egypt. Trop Anim Health Prod Res, 56(6) : 205.
[97] Wang M,Xin Y,Cao H .2021 .Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery. Biomater Sci, 9(4) : 1088-1103.
[98] Wang S,Hofacre CL,Wanda S-Y .2022 .A triple-sugar regulated Salmonella vaccine protects against Clostridium perfringensinduced necrotic enteritis in broiler chickens. Polut Sci, 101 : 101592.
[99] Wang Y,Miao Y,Hu L .2020 .Immunization of mice against alpha, beta, and epsilon toxins of Clostridium perfringens using recombinant rCpa-bx expressed by Bacillus subtilis. Mol Immunol, 123 : 88-96.
[100] Xu B,Shaoyong W,Wang L .2023 .Gut-targeted nanoparticles deliver specifically targeted antimicrobial peptides against Clostridium perfringens infections. Sci Adv, 9(39) : eadf8782.
[101] Yadav JP,Kaur S .2022 .molecular characterization and antimicrobial resistance profile of Clostridium perfringens from India: A scoping review. Anaerobe, 77 : 102639.
[102] Yang J,Zhang X,Liu C .2021 .Biologically modified nanoparticles as theranostic bionanomaterials. Prog Mater Sci, 118 : 100768.
[103] Yetisgin AA,Cetinel S,Zuvin M .2020 .Therapeutic nanoparticles and their targeted delivery applications. Molecules, 25(9) : 2193.
[104] Zgheib H,Belguesmia Y,Boukherroub R .2021 .Alginate nanoparticles enhance anti-Clostridium perfringens activity of the leaderless two-peptide enterocin DD14 and affect expression of some virulence factors. Probioti Antimicrob Prot, 13 : 1213-1227.
[105] Zhang Y,Zhang Q,Li C .2024 .Advances in cell membrane-based biomimetic nanodelivery systems for natural products. Drug Deliv, 31(1) : 2361169.
[106] Zhang Z,He X,Zhou C .2020 .Iron magnetic nanoparticle-induced ROS generation from catechol-containing microgel for environmental and biomedical applications. ACS Appl Mater Interf, 12(19) : 21210-21220.